Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD. (2022)

First Author: Hanson B
Attributed to:  Antisense Oligonucleotide Therapy for Neuromuscular Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtn.2022.10.010

PubMed Identifier: 36420212

Publication URI: http://europepmc.org/abstract/MED/36420212

Type: Journal Article/Review

Volume: 30

Parent Publication: Molecular therapy. Nucleic acids

ISSN: 2162-2531